Melanoma vaccine (Sanofi Pasteur)

N/A

Report date: 2025/08/19 20:00:08

Base Information

Drug NameMelanoma vaccine (Sanofi Pasteur)
Drug Alias NameALVAC-gp100
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
Targets +[1N/A
Therapy Area/IndicationsSkin NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi Pasteur
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsSkin NeoplasmsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A